PFE Pfizer Inc

Price (delayed)

$41.49

Market cap

$232.62B

P/E Ratio

17.58

Dividend/share

$1.55

EPS

$2.36

Enterprise value

$269.49B

Pfizer Inc. is an American multinational pharmaceutical corporation. It is one of the world's largest pharmaceutical companies and ranked 57 on the 2018 Fortune 500 list of the largest United ...

Highlights
Pfizer's revenue has increased by 49% YoY and by 21% QoQ
PFE's debt is down by 38% YoY
Pfizer's net income has increased by 19% QoQ but it has decreased by 7% YoY
Pfizer's EPS has increased by 18% from the previous quarter but it has decreased by 7% YoY
The gross margin has contracted by 12% YoY and by 8% from the previous quarter

Key stats

What are the main financial stats of PFE
Market
Shares outstanding
5.61B
Market cap
$232.62B
Enterprise value
$269.49B
Valuations
Price to earnings (P/E)
17.58
Price to book (P/B)
3.32
Price to sales (P/S)
4.5
EV/EBIT
18.51
EV/EBITDA
13.88
EV/Sales
5.22
Earnings
Revenue
$51.64B
EBIT
$14.56B
EBITDA
$19.42B
Free cash flow
$20.64B
Per share
EPS
$2.36
Free cash flow per share
$3.69
Book value per share
$12.51
Revenue per share
$9.22
TBVPS
$16.56
Balance sheet
Total assets
$169.92B
Total liabilities
$99.61B
Debt
$39.24B
Equity
$70.04B
Working capital
$13.15B
Liquidity
Debt to equity
0.56
Current ratio
1.37
Quick ratio
0.91
Net debt/EBITDA
1.9
Margins
EBITDA margin
37.6%
Gross margin
70.4%
Net margin
25.6%
Operating margin
23.1%
Efficiency
Return on assets
8%
Return on equity
19.8%
Return on invested capital
14.9%
Return on capital employed
10.8%
Return on sales
28.2%
Dividend
Dividend yield
3.74%
DPS
$1.55
Payout ratio
65.7%

PFE stock price

How has the Pfizer stock price performed over time
Intraday
-0.43%
1 week
-2.26%
1 month
-7.33%
1 year
13.52%
YTD
12.71%
QTD
-3.53%

Financial performance

How have Pfizer's revenue and profit performed over time
Revenue
$51.64B
Gross profit
$36.34B
Operating income
$11.95B
Net income
$13.23B
Gross margin
70.4%
Net margin
25.6%
Pfizer's revenue has increased by 49% YoY and by 21% QoQ
The operating income has grown by 43% from the previous quarter
PFE's net margin is down by 37% YoY and by 2.3% from the previous quarter
Pfizer's gross profit has increased by 31% YoY and by 12% from the previous quarter

Growth

What is Pfizer's growth rate over time

Valuation

What is Pfizer stock price valuation
P/E
17.58
P/B
3.32
P/S
4.5
EV/EBIT
18.51
EV/EBITDA
13.88
EV/Sales
5.22
Pfizer's EPS has increased by 18% from the previous quarter but it has decreased by 7% YoY
The price to earnings (P/E) is 11% lower than the last 4 quarters average of 19.8
Pfizer's equity has increased by 9% YoY and by 2.1% QoQ
PFE's P/B is 7% above its last 4 quarters average of 3.1
Pfizer's revenue has increased by 49% YoY and by 21% QoQ
PFE's P/S is 10% below its last 4 quarters average of 5.0 and 4.3% below its 5-year quarterly average of 4.7

Efficiency

How efficient is Pfizer business performance
Pfizer's ROS has decreased by 39% YoY
The company's return on invested capital rose by 30% QoQ but it fell by 10% YoY
Pfizer's ROA has increased by 19% from the previous quarter but it has decreased by 3.6% YoY
The ROE rose by 16% QoQ but it fell by 10% YoY

Dividends

What is PFE's dividend history
DPS
$1.55
Dividend yield
3.74%
Payout ratio
65.7%
Recent dividends

Financial health

How did Pfizer financials performed over time
PFE's total assets is 71% greater than its total liabilities
The company's total liabilities fell by 12% YoY but it rose by 11% QoQ
The current ratio has contracted by 7% from the previous quarter and by 3.5% YoY
PFE's debt is 44% less than its equity
The debt to equity has contracted by 43% YoY and by 3.4% from the previous quarter
PFE's debt is down by 38% YoY

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.